[1]
Mustafa, M.J.A., Mohamed, M.B. and Hayat, A. 2017. Tumour Lysis Syndrome and Partial Remission Occurring After Administration of a Test Dose of Obinutuzumab. European Journal of Case Reports in Internal Medicine. 4, 1 (Jan. 2017). DOI:https://doi.org/10.12890/2016_000516.